In this presentation, you will learn:
- Illumina TSO500 ctDNA assay details and validation goals
- Description of various reference material used in IQVIA Laboratories validation
- How performance of reference material compares to diseases plasma samples
- Pros and cons of using reference material
- Validation results
Download presentation to learn more.
Related Insights

Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials

Biorepository and Specimen Management
Your biological specimens are irreplaceable assets – trust them with a proven partner

ADME Services
Accelerating your drug discovery, preclinical and clinical programs

IQVIA Laboratories Central Laboratory Services
Central laboratory solutions supporting clinical trials around the world

Helping you master your lab data
Improved oversight with your lab data now in full view

NASH and Liver Disease Capabilities
Nonalcoholic Fatty Liver Diseases & Non-alcoholic Steatohepatitis (NAFLD & NASH)

How COVID-19 Changed Clinical Trial Dynamics and Environment
Precision Medicine World Conference 2021 Virtual Presentation

Pediatric Initiative
Optimizing small blood volumes to prevent canceled tests in clinical trials for pediatric patients
Vaccine Laboratory Services
Test Menu

SARS-CoV-2 Vaccine Induced Antibody Profiles
Presented at World Vaccine Congress 2021